Details for Patent: 4,952,586
✉ Email this page to a colleague
Summary for Patent: 4,952,586
Title: | Edrophonium-atropine composition and therapeutic uses thereof |
Abstract: | A composition is provided which includes a balanced combination of an edrophonium component and an atropine component. A preferred embodiment has 0.5 mg of edrophonium chloride and 8 micrograms of atropine sulfate, with respect to patient weight. The inventive composition is useful to antagonize nondepolarizing blockade during medical treatment when muscle relaxation is no longer necessary, provides extremely rapid onset of action and results in minimal heart rate changes. |
Inventor(s): | Morris; Robert B. (Mill Valley, CA), Cronnelly; Roy (Pacifica, CA), Miller; Ronald Dean (Greenbrae, CA) |
Assignee: | The Regents of the University of California (Berkeley, CA) |
Application Number: | 07/262,175 |
Patent Claim Types: see list of patent claims | Composition; Formulation; Use; | More… ↓ |
Drugs Protected by US Patent 4,952,586
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 4,952,586
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 1200500 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |